{
    "uniprot_canonical_ac": "A0A140T858-1",
    "uniprot_id": [
        {
            "id": "A0A140T858_BOVIN",
            "url": "https://www.uniprot.org/uniprot/A0A140T858_BOVIN",
            "type": "external"
        }
    ],
    "mass": 48767.0,
    "length": 454,
    "protein_name": "Gastrin/cholecystokinin type B receptor",
    "gene_name": "CCKBR",
    "organism": "Bovine",
    "refseq_name": "gastrin/cholecystokinin type B receptor",
    "refseq_ac": [
        {
            "id": "NP_776687",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_776687",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "CCKBR",
    "gene_names_refseq": "CCKBR",
    "protein_names_uniprotkb": "Gastrin/cholecystokinin type B receptor; Cholecystokinin-2 receptor",
    "protein_names_refseq": "CCK2 receptor; CCK-BR; CCK2-R; CCK-B receptor; cholecystokinin-2 receptor; gastrin/cholecystokinin type B receptor",
    "tax_id": 9913,
    "disease": "",
    "pathway": " (bta:281665);  (R-BTA-375276);  (R-BTA-416476);  (R-BTA-881907)",
    "pathway_count": 4,
    "publication_count": 0,
    "publication_id_list": "",
    "function": "Receptor for gastrin and cholecystokinin. The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system., [UniProtKB, UniProtKB, UniProtKB]",
    "predicted_glycosites": 2,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 2,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 2,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 0,
    "glyco_site_count": 2,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0015054 gastrin receptor activity;GO:0008188 neuropeptide receptor activity;GO:0004951 cholecystokinin receptor activity",
    "go_cellular_component": "GO:0005886 plasma membrane",
    "go_biological_process": "GO:0007218 neuropeptide signaling pathway;GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway",
    "synthesized_glycan_count": 0,
    "record_id": "A0A140T858-1",
    "record_type": "protein",
    "filter_code": "0000000.0000001.100000.0100000000000000.00010.001"
}